338 related articles for article (PubMed ID: 9545244)
1. Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments.
Nutt SL; Morrison AM; Dörfler P; Rolink A; Busslinger M
EMBO J; 1998 Apr; 17(8):2319-33. PubMed ID: 9545244
[TBL] [Abstract][Full Text] [Related]
2. Essential functions of Pax-5 (BSAP) in pro-B cell development.
Nutt SL; Thévenin C; Busslinger M
Immunobiology; 1997 Dec; 198(1-3):227-35. PubMed ID: 9442394
[TBL] [Abstract][Full Text] [Related]
3. Loss- and gain-of-function mutations reveal an important role of BSAP (Pax-5) at the start and end of B cell differentiation.
Morrison AM; Nutt SL; Thévenin C; Rolink A; Busslinger M
Semin Immunol; 1998 Apr; 10(2):133-42. PubMed ID: 9618759
[TBL] [Abstract][Full Text] [Related]
4. C-terminal activating and inhibitory domains determine the transactivation potential of BSAP (Pax-5), Pax-2 and Pax-8.
Dörfler P; Busslinger M
EMBO J; 1996 Apr; 15(8):1971-82. PubMed ID: 8617244
[TBL] [Abstract][Full Text] [Related]
5. Pax-5 (BSAP) recruits Ets proto-oncogene family proteins to form functional ternary complexes on a B-cell-specific promoter.
Fitzsimmons D; Hodsdon W; Wheat W; Maira SM; Wasylyk B; Hagman J
Genes Dev; 1996 Sep; 10(17):2198-211. PubMed ID: 8804314
[TBL] [Abstract][Full Text] [Related]
6. Fidelity and infidelity in commitment to B-lymphocyte lineage development.
Rolink AG; Schaniel C; Busslinger M; Nutt SL; Melchers F
Immunol Rev; 2000 Jun; 175():104-11. PubMed ID: 10933595
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of BSAP/Pax-5 inhibits switching to IgA and enhances switching to IgE in the I.29 mu B cell line.
Qiu G; Stavnezer J
J Immunol; 1998 Sep; 161(6):2906-18. PubMed ID: 9743352
[TBL] [Abstract][Full Text] [Related]
8. Early function of Pax5 (BSAP) before the pre-B cell receptor stage of B lymphopoiesis.
Thévenin C; Nutt SL; Busslinger M
J Exp Med; 1998 Aug; 188(4):735-44. PubMed ID: 9705955
[TBL] [Abstract][Full Text] [Related]
9. Pax-5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS, and adult testis.
Adams B; Dörfler P; Aguzzi A; Kozmik Z; Urbánek P; Maurer-Fogy I; Busslinger M
Genes Dev; 1992 Sep; 6(9):1589-607. PubMed ID: 1516825
[TBL] [Abstract][Full Text] [Related]
10. The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP.
Kozmik Z; Wang S; Dörfler P; Adams B; Busslinger M
Mol Cell Biol; 1992 Jun; 12(6):2662-72. PubMed ID: 1375324
[TBL] [Abstract][Full Text] [Related]
11. Requirements for selective recruitment of Ets proteins and activation of mb-1/Ig-alpha gene transcription by Pax-5 (BSAP).
Maier H; Ostraat R; Parenti S; Fitzsimmons D; Abraham LJ; Garvie CW; Hagman J
Nucleic Acids Res; 2003 Oct; 31(19):5483-9. PubMed ID: 14500810
[TBL] [Abstract][Full Text] [Related]
12. DNA sequence recognition by Pax proteins: bipartite structure of the paired domain and its binding site.
Czerny T; Schaffner G; Busslinger M
Genes Dev; 1993 Oct; 7(10):2048-61. PubMed ID: 8406007
[TBL] [Abstract][Full Text] [Related]
13. The transcription factor B-cell-specific activator protein is not involved in the IL-4-induced activation of the human IgE germline promoter.
Albrecht B; Peiritsch S; Messner B; Woisetschläger M
J Immunol; 1996 Aug; 157(4):1538-43. PubMed ID: 8759736
[TBL] [Abstract][Full Text] [Related]
14. The murine Ig 3' alpha enhancer is a target site with repressor function for the B cell lineage-specific transcription factor BSAP (NF-HB, S alpha-BP).
Neurath MF; Strober W; Wakatsuki Y
J Immunol; 1994 Jul; 153(2):730-42. PubMed ID: 8021508
[TBL] [Abstract][Full Text] [Related]
15. Neuroblastoma and pre-B lymphoma cells share expression of key transcription factors but display tissue restricted target gene expression.
Lagergren A; Manetopoulos C; Axelson H; Sigvardsson M
BMC Cancer; 2004 Nov; 4():80. PubMed ID: 15544702
[TBL] [Abstract][Full Text] [Related]
16. Dependence of BSAP repressor and activator functions on BSAP concentration.
Wallin JJ; Gackstetter ER; Koshland ME
Science; 1998 Mar; 279(5358):1961-4. PubMed ID: 9506950
[TBL] [Abstract][Full Text] [Related]
17. Regulation of mouse CD72 gene expression during B lymphocyte development.
Ying H; Healy JI; Goodnow CC; Parnes JR
J Immunol; 1998 Nov; 161(9):4760-7. PubMed ID: 9794407
[TBL] [Abstract][Full Text] [Related]
18. Id helix-loop-helix proteins antagonize pax transcription factor activity by inhibiting DNA binding.
Roberts EC; Deed RW; Inoue T; Norton JD; Sharrocks AD
Mol Cell Biol; 2001 Jan; 21(2):524-33. PubMed ID: 11134340
[TBL] [Abstract][Full Text] [Related]
19. In vivo footprinting and mutational analysis of the proximal CD19 promoter reveal important roles for an SP1/Egr-1 binding site and a novel site termed the PyG box.
Riva A; Wilson GL; Kehrl JH
J Immunol; 1997 Aug; 159(3):1284-92. PubMed ID: 9233624
[TBL] [Abstract][Full Text] [Related]
20. The role of BSAP (Pax-5) in B-cell development.
Busslinger M; Urbánek P
Curr Opin Genet Dev; 1995 Oct; 5(5):595-601. PubMed ID: 8664547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
